The in vitro inhibitory activity of the hybrid compounds 4 and 6 on the proliferation of HCC cell lines were correlated with the inhibitory activity against Raf kinases, and the degree of inhibitory activity was strong in the order of sorafenib, 6, and 4. Here, RAF1 is linked to hepatocellular carcinoma.